JCLGX
Price
$14.38
Change
-$0.03 (-0.21%)
Updated
May 23 closing price
Net Assets
8.24B
JTLGX
Price
$14.47
Change
-$0.02 (-0.14%)
Updated
May 23 closing price
Net Assets
8.24B
Interact to see
Advertisement

JCLGX vs JTLGX

Header iconJCLGX vs JTLGX Comparison
Open Charts JCLGX vs JTLGXBanner chart's image
JHancock Multimanager Lifestyle Gr C
Price$14.38
Change-$0.03 (-0.21%)
VolumeN/A
Net Assets8.24B
JHancock Multimanager Lifestyle Gr R5
Price$14.47
Change-$0.02 (-0.14%)
VolumeN/A
Net Assets8.24B
JCLGX vs JTLGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JCLGX vs. JTLGX commentary
May 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JCLGX is a Hold and JTLGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JCLGX (8.24B) and JTLGX (8.24B) have equal amount of cash in the bank . JTLGX pays higher dividends than JCLGX: JTLGX (2.35) vs JCLGX (1.31). JCLGX was incepted earlier than JTLGX: JCLGX (20 years) vs JTLGX (20 years). JCLGX (2.08) is less costly to investors than JTLGX (1.02). JCLGX (13.00) and JTLGX (13.00) have comparable annual turnover. JTLGX has a lower initial minimum investment than JCLGX: JTLGX (0) vs JCLGX (1000). JTLGX annual gain was more profitable for investors over the last year : 6.95 vs. JCLGX (5.83). JTLGX return over 5 years is better than : 21.85 vs. JCLGX (16.60).
JCLGXJTLGXJCLGX / JTLGX
Total Expense Ratio2.081.02204%
Annual Report Gross Expense Ratio2.081.02204%
Fund Existence20 years20 years-
Gain YTD2.0542.47583%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets8.24B8.24B100%
Annual Yield % from dividends1.312.3556%
Returns for 1 year5.836.9584%
Returns for 3 years6.449.2470%
Returns for 5 years16.6021.8576%
Returns for 10 years-7.61-0.302,535%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LAFQX18.94N/A
N/A
Lord Abbett Affiliated R2
GSMAX19.37N/A
N/A
Goldman Sachs Small/Mid Cap Growth A
RSPYX29.52N/A
N/A
Victory RS Partners Y
HCPIX89.03N/A
N/A
ProFunds UltraSector Health Care Inv
BHCUX17.42N/A
N/A
Baron Health Care R6